Baird Downgrades Robbins & Myers (RBN) to Neutral
More News related to RBN
- Notable Analyst Rating Changes 7/1: SIRI, AXP, NVDA, CTAS Upgraded; FO, ALTR, RBN Downgraded
- BB&T Downgrades Robbins & Myers (RBN) to Hold
- Unusual 11 Mid-Day Movers 6/30: DDSS, HYGS, RBN, NNDS Higher; TCM, JADE, PRC, SHFL Lower
- Robbins & Myers Issues Corrected Conference Call Information
- Robbins & Myers, Inc. (RBN) Tops Q3 EPS by 4c, Guides Higher for FY
Baird downgrades Robbins & Myers (NYSE: RBN) from Outperform to Neutral, but increased price target from $76 to $80.
Robbins & Myers Inc. is engaged in supplying of engineered equipment and systems for applications in global energy, industrial, chemical and pharmaceutical markets.
Related Categories
DowngradesStocks Mentioned
-2.92Sign up for StreetInsider Free!
Recieve full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
